Last update 23 Jan 2025

STING x αvβ1

Basic Info

Related Targets
STINGαvβ1

Related

1
Drugs associated with STING x αvβ1
VAX-014
Target
STING x αvβ1
Mechanism
STING agonists [+1]
Active Org.
Vaxiion Therapeutics, Inc.Vaxiion Therapeutics, Inc.
Originator Org.
Vaxiion Therapeutics, Inc.Vaxiion Therapeutics, Inc.
Active Indication
Advanced Malignant Solid Neoplasm [+2]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
2
Clinical Trials associated with STING x αvβ1
NCT05901285
/ RecruitingPhase 1
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid
NCT03854721
/ CompletedPhase 1
Phase I Safety and Tolerability of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer (NMIBC)
100 Clinical Results associated with STING x αvβ1
Login to view more data
100 Translational Medicine associated with STING x αvβ1
Login to view more data
0 Patents (Medical) associated with STING x αvβ1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free